Results 91 to 100 of about 103,527,733 (191)
Minocycline in phenotypic models of Huntington's disease
Minocycline has been shown to be neuroprotective in various models of neurodegenerative diseases. However, its potential in Huntington's disease (HD) models characterized by calpain-dependent degeneration and inflammation has not been investigated. Here,
Kadiombo Bantubungi +15 more
doaj +1 more source
Friedreich ataxia (FRDA) is the most common recessive ataxia caused by reduced expression of frataxin, a nuclear encoded mitochondrial protein. In this study we examined the effects of 3-nitropropionic acid (3-NP) on frataxin expression in FRDA patient ...
RUGGIERO, GIUSEPPINA +7 more
core
NR2B subunit blockade does not affect motor symptoms induced by 3-nitropropionic acid
Broad-spectrum N-methyl D-aspartate (NMDA) antagonists, although proposed in therapies for several pathologies including Huntington's disease (HD), can produce dramatic side-effects.
Morari, Michele +9 more
core +1 more source
Avaliação do potencial efeito protetor do probucol em modelos experimentais da doença de Huntington [PDF]
Dissertação (mestrado) - Universidade Federal de Santa Catarina, Centro de Ciências Biológicas. Programa de Pós-Graduação em BioquímicaA doença de Huntington (DH) é uma patologia neurodegenerativa, autossômica dominante caracterizada por sintomas ...
Colle, Dirleise
core
Embargado hasta 01/01/2100.Objective: This study sought to determine whether melatonin causes changes in neurotrophic factors and it protects against the mycotoxin 3-nitropropionic acid (3-NP) in brain tissue.
Delgado, María J +23 more
core +1 more source
3-Nitropropionic acid and 3-nitro-1-propanol in species of Astragalus
Leaves of nitro-bearing species of Astragalus collected from North American and European herbaria were analyzed for types of toxic aliphatic nitro compounds. The nitro compounds were extracted and hydrolized to 3-nitropropionic acid (3-NPA) or 3-nitro-1-
M. C. Williams
core +1 more source
(M.A.) -- Towson University, 2017The current study attempted to evaluate sex differences in procedural learning and memory deficits in mice using intraperitoneal (i.p.) injections of 3-nitropropionic acid (3NP).
Haines, Kari M.
core +1 more source
Circadian Dysfunction in Response to Treatment with the Mitochondrial Toxin 3-Nitropropionic Acid
Sleep disorders are common in neurodegenerative diseases including Huntington's disease (HD) and develop early in the disease process. Mitochondrial alterations are believed to play a critical role in the pathophysiology of neurodegenerative diseases. In
Takashi Kudo +5 more
doaj +1 more source
3−Nitropropionic acid (3−NPA) is a metabolic poison that produces lesions of striatal intrinsic neurones such as γ-aminobutyric acid (GABA) neurones. This study was carried out to determine whether 3−NPA would impair the ability of striatal GABAergic ...
A Boireau, A Doble, M Meunier
core +1 more source
Topological analysis of striatal lesions induced by 3-nitropropionic acid in the Lewis rat.
3-Nitropropionic acid (3NP) is a succinate dehydrogenase inhibitor classically used to create animal models of Huntington's disease (HD). However, the effects of this neurotoxin are highly variable in the Sprague-Dawley rat strain, impeding the interest ...
Schiffmann, Serge N. +10 more
core +1 more source

